Experience
Eli Lilly and Company v. Genentech, Inc.
Eli Lilly and Company
Genentech, Inc.
Successfully represented Lilly in post-grant review (PGR) proceeding relating to patent on IL-17A/F antibodies that had been asserted against Lilly’s blockbuster Taltz® pharmaceutical and in parallel district court litigation. Achieved institution of PGR, judgment in favor of petitioner, and dismissal of the district court case.
Eli Lilly and Company v. Genentech, Inc., PGR2019-00043, PTAB, Judges Mitchell, Paulraj, Cotta
Genentech, Inc. v. Eli Lilly and Company, 3:18-cv-01518, S.D. Cal., Judge Sammartino
